Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/143525
Title: Transdermal drug delivery systems : a risk analysis
Authors: Sultana, Isabelle
Attard Pizzuto, Maresca
Azzopardi, Lilian M.
Keywords: Transdermal medication -- Malta
Drug delivery systems
Pharmaceutical industry -- Standards
Medication errors
Patient satisfaction
Issue Date: 2025-05
Publisher: University of Malta. Department of Pharmacy
Citation: Sultana, I., Attard Pizzuto, M., & Azzopardi, L. M. (2025, May). Transdermal drug delivery systems : a risk analysis. EAFP - Annual Conference, Coimbra.
Abstract: Following the introduction of the scopolamine transdermal drug delivery system (TDDS) in 1979 approved by the US-Food and Drug Administration, TDDS has been applied to different active ingredients. The choice of the active ingredient as a candidate for TDDS relied on pharmacokinetic profile, dosage frequency and use characteristics. Despite the availability of the system for the past forty years, the dosage form is challenged with lack of popularity. The aim of this study was to understand reasons for lack of popularity by establishing a framework for the risk analysis of TDDS. [excerpt]
URI: https://www.um.edu.mt/library/oar/handle/123456789/143525
Appears in Collections:Scholarly Works - FacM&SPha

Files in This Item:
File Description SizeFormat 
Transdermal_drug_delivery_systems_a_risk_analysis(2025).pdf532.3 kBAdobe PDFView/Open


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.